These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31066988)

  • 1. Effect of Local Polyhexanide Application in Preventing Exit-Site Infection and Peritonitis: A Randomized Controlled Trial.
    Ceri M; Yilmaz SR; Unverdi S; Kurultak I; Duranay M
    Ther Apher Dial; 2020 Feb; 24(1):81-84. PubMed ID: 31066988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
    Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. results of a prospective randomized trial.
    Núñez-Moral M; Sánchez-Álvarez E; González-Díaz I; Peláez-Requejo B; Fernández-Viña A; Quintana-Fernández A; Rodríguez-Suárez C
    Perit Dial Int; 2014 May; 34(3):271-7. PubMed ID: 24497599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparison of exit-site care with normal saline and povidone-iodine in preventing exit-site infection and peritonitis in children on chronic peritoneal dialysis treatment.
    Yavascan O; Anil M; Kara OD; Bal A; Akcan N; Senturk S; Unturk S; Aksu N
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):931-4. PubMed ID: 21912021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Sequential Comparison of Topical Application of Medicated Honey and Povidone Iodine for Preventing Peritoneal Dialysis Catheter-Related Infections.
    Wishart TFL; Aw L; Byth K; Rangan G; Sud K
    Perit Dial Int; 2018; 38(4):302-305. PubMed ID: 29987066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
    Pierce DA; Williamson JC; Mauck VS; Russell GB; Palavecino E; Burkart JM
    Perit Dial Int; 2012; 32(5):525-30. PubMed ID: 22302770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
    Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing Peritoneal Dialysis Infections.
    Bolton L
    Wounds; 2019 Jun; 31(6):163-165. PubMed ID: 31215869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
    Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
    Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sucrose and povidone-iodine mixtures in peritoneal dialysis catheter exit-site care.
    Nakayama T; Morimoto K; Uchiyama K; Washida N; Kusahana E; Hama EY; Mitsuno R; Tonomura S; Yoshimoto N; Hishikawa A; Hagiwara A; Azegami T; Yoshino J; Monkawa T; Yoshida T; Yamaguchi S; Hayashi K
    BMC Nephrol; 2024 May; 25(1):151. PubMed ID: 38698327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
    Sachar M; Shah A
    Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
    Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.